Clinic
Muskingum Valley Health Centers
Muskingum Valley Health Centers was paid $28.59M by Medicaid between Jan 2018 and Dec 2024, across 171 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 55% of everything it billed.
33Billing provider infoMUSKINGUM VALLEY HEALTH CENTERS
ZANESVILLE, OH 43701
ZANESVILLE, OH 43701
33aNPI1841472982assigned 11/30/2007
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$28.59M
24GClaims2,067,797
24DCodes billed171
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Ohio
Rank by total paid#4 of 348
Median peer was paid$1.33M
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ATKINSON, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 291,107 | $4.10M | |
| 2019 | 324,439 | $4.62M | |
| 2020 | 380,409 | $4.72M | |
| 2021 | 314,603 | $4.60M | |
| 2022 | 273,469 | $3.87M | |
| 2023 | 320,614 | $4.15M | |
| 2024incomplete | 163,156 | $2.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 55% | 228,246 | 167,308 | $15.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 203,271 | 110,433 | $4.22M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.6% | 45,534 | 25,878 | $1.31M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.2% | 46,104 | 21,315 | $927K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.1% | 41,188 | 19,769 | $596K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 13,442 | 8,164 | $456K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 27,789 | 16,059 | $374K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1.2% | 15,963 | 12,680 | $343K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 10,699 | 6,214 | $330K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 11,286 | 6,469 | $324K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,989 | 2,790 | $252K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 6,618 | 3,987 | $236K |
159 more codes
| D0120 | Dental checkup, returning patient | <1% | 21,213 | $213K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 6,752 | $203K |
| 90670 | <1% | 5,827 | $199K | |
| D1110 | Prophylaxis - adult | <1% | 11,347 | $193K |
| D1120 | Dental cleaning, child | <1% | 16,098 | $191K |
| Q3014 | Telehealth originating site facility fee | <1% | 20,755 | $185K |
| D1206 | Topical application of fluoride varnish | <1% | 19,542 | $166K |
| 90837 | Psychotherapy session, about an hour | <1% | 4,053 | $155K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 5,805 | $149K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 10,001 | $131K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,200 | $118K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 4,389 | $118K |
| D0330 | Panoramic radiographic image | <1% | 5,470 | $116K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 25,485 | $94K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,893 | $92K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 3,370 | $83K |
| 92551 | <1% | 23,129 | $81K | |
| D0274 | Bitewings - four radiographic images | <1% | 8,693 | $69K |
| D0140 | Limited oral evaluation - problem focused | <1% | 7,307 | $67K |
| 36415 | Collection of venous blood by venipuncture | <1% | 33,405 | $47K |
| 80305 | <1% | 8,270 | $46K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 2,919 | $46K |
| 99188 | <1% | 3,684 | $43K | |
| 90698 | <1% | 3,463 | $43K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,676 | $43K |
| 90633 | <1% | 2,892 | $41K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,132 | $40K |
| 90651 | <1% | 1,581 | $40K | |
| 99174 | <1% | 6,700 | $36K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,100 | $31K |
| 90686 | <1% | 10,819 | $31K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 2,753 | $28K |
| D0272 | Bitewings - two radiographic images | <1% | 5,434 | $27K |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 4,462 | $27K |
| 81025 | <1% | 5,009 | $23K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,284 | $23K |
| 99177 | <1% | 4,311 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 889 | $19K |
| 99401 | <1% | 1,133 | $18K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 2,454 | $18K |
| D1351 | Sealant - per tooth | <1% | 1,384 | $17K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 7,316 | $16K |
| 90734 | <1% | 1,056 | $15K | |
| 96127 | <1% | 6,728 | $15K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 371 | $14K |
| 11720 | <1% | 1,953 | $13K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 402 | $13K |
| 90710 | <1% | 529 | $12K | |
| 96161 | <1% | 7,253 | $11K | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 417 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,420 | $10K |
| 82962 | <1% | 7,966 | $9K | |
| 99381 | <1% | 258 | $8K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 268 | $7K |
| 90381 | <1% | 14 | $6K | |
| 90716 | <1% | 157 | $6K | |
| 90697 | <1% | 2,347 | $4K | |
| 90707 | <1% | 172 | $4K | |
| 36416 | <1% | 1,888 | $4K | |
| 99173 | <1% | 2,976 | $4K | |
| D0270 | <1% | 1,921 | $4K | |
| 85018 | <1% | 2,681 | $3K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,593 | $3K |
| 0071A | <1% | 62 | $3K | |
| 96160 | <1% | 1,776 | $3K | |
| 80061 | Lipid panel | <1% | 334 | $3K |
| D1354 | <1% | 195 | $2K | |
| 0072A | <1% | 52 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 325 | $2K |
| 90480 | <1% | 84 | $2K | |
| 90744 | <1% | 1,808 | $2K | |
| 81003 | <1% | 2,228 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 38 | $2K |
| 90681 | <1% | 2,178 | $2K | |
| 99385 | <1% | 95 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 101 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 55 | $2K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 58 | $2K |
| 0002A | <1% | 28 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 32 | $1K |
| 99384 | <1% | 21 | $1K | |
| 90715 | <1% | 275 | $1K | |
| 0134A | <1% | 25 | $964.12 | |
| 10060 | <1% | 14 | $855.52 | |
| 90671 | <1% | 415 | $775.53 | |
| 0064A | <1% | 13 | $767.39 | |
| 90696 | <1% | 461 | $704.61 | |
| D2330 | <1% | 24 | $645.24 | |
| 99383 | <1% | 21 | $641.34 | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $628.52 |
| 11730 | <1% | 20 | $557.74 | |
| 11721 | <1% | 32 | $466.08 | |
| 90685 | <1% | 220 | $388.00 | |
| 90700 | <1% | 365 | $385.63 | |
| 90656 | <1% | 521 | $322.73 | |
| 90677 | <1% | 1,059 | $288.66 | |
| 90648 | <1% | 72 | $260.36 | |
| 90474 | <1% | 152 | $244.24 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 301 | $243.36 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | $213.70 |
| 82950 | <1% | 125 | $204.60 | |
| 82044 | <1% | 205 | $167.35 | |
| 90619 | <1% | 400 | $158.06 | |
| 99441 | <1% | 42 | $140.56 | |
| 90461 | <1% | 8,003 | $130.00 | |
| 90473 | <1% | 44 | $93.90 | |
| 87210 | <1% | 65 | $54.12 | |
| 90620 | <1% | 167 | $25.75 | |
| 94760 | <1% | 1,163 | $9.59 | |
| 91313 | <1% | 56 | $0.22 | |
| 3017F | 0% | 36,912 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 18,343 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 27,219 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 66,926 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 756 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 73,280 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 67,924 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 28,839 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 31,033 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 1,204 | $0.00 |
| G8405 | Lower extremity neurological exam not performed | 0% | 3,744 | $0.00 |
| 1036F | 0% | 89,990 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 3,790 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 31,504 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 3,746 | $0.00 |
| 3014F | 0% | 2,847 | $0.00 | |
| 3074F | 0% | 5,717 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 4,839 | $0.00 |
| 3044F | 0% | 1,171 | $0.00 | |
| 3079F | 0% | 1,768 | $0.00 | |
| 3080F | 0% | 344 | $0.00 | |
| 3075F | 0% | 555 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 79 | $0.00 |
| G9231 | Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period | 0% | 205 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 14 | $0.00 |
| 1111F | 0% | 267 | $0.00 | |
| 93000 | 0% | 15 | $0.00 | |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | 0% | 29 | $0.00 |
| 90647 | 0% | 33 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 79,310 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 107,519 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 8,741 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 165,509 | $0.00 |
| 4004F | 0% | 82,352 | $0.00 | |
| 2022F | 0% | 3,432 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 26,847 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 16,288 | $0.00 |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 0% | 4,974 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 2,779 | $0.00 |
| 3078F | 0% | 5,282 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 448 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 2,572 | $0.00 |
| 3046F | 0% | 1,767 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 1,510 | $0.00 |
| 3077F | 0% | 970 | $0.00 | |
| 81002 | 0% | 49 | $0.00 | |
| 3045F | 0% | 544 | $0.00 | |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 138 | $0.00 |
| 69209 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialATKINSON, DANIEL (CEO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.